- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07487688
Five-Year CT Follow-Up of Vertebral Fracture Risk Using Opportunistic Osteoporosis Screening
March 25, 2026 updated by: Maximilian Löffler, Technical University of Munich
CTFU: Five-Year Computed Tomography Follow-Up Study of Vertebral Fracture Risk Using Opportunistic Screening for Osteoporosis
This study evaluates whether opportunistic osteoporosis screening using routinely acquired computed tomography (CT) scans improves fracture risk prediction compared with guideline-recommended FRAX-based screening from age 50.
In current practice, few high-risk individuals identified by FRAX actually receive confirmatory dual-energy X-ray absorptiometry (DXA), despite the growing health and economic burden of osteoporotic fractures.
Volumetric bone mineral density (vBMD) and CT-based detection of vertebral fractures can be extracted from existing CT images obtained for other indications, offering a non-invasive way to capture key determinants of fracture and mortality risk, including low BMD, age, and prevalent fractures.
The trial therefore compares the diagnostic performance of FRAX major osteoporotic fracture risk versus CT-derived vBMD and CT-identified vertebral fractures for predicting incident vertebral fractures in older adults.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Primary objective: To assess the predictive performance of opportunistic volumetric bone mineral density (vBMD) from routine thoracoabdominal CT scans for incident vertebral fractures over 5 years or longer.
Secondary objectives:
- To compare the performance of vBMD to predict incident vertebral fractures with other predictors, including demographic and clinical risk factors, FRAX algorithm scores for 5-year risk of major osteoporotic fractures (MOF), prevalent vertebral fractures, and prevalent clinical fractures, as well as combinations of these predictors.
- To stratify the analyses based on age decades and sex.
- To compare the predictive performance between CT scans with and without administration of i.v. contrast medium.
- To compare the predictive performance of vBMD (using asynchronous calibration) with Hounsfield units
- To describe the prevalence and incidence (in fractures per person-years) of the study population
- Assessment of the impact of a preventive treatment of patients at high risk of fracture in terms of the number of avoided fractures (simulation study)
Study Type
Observational
Enrollment (Actual)
2799
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
München, Germany, 81675
- Klinikum Rechts der Isar
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Consecutive patients from the local imaging database that received a CT scan including at least T6 to L4 (=baseline) and a second CT scan after at least 5 years including at least T6 to L4 (=5 years follow-up)
Description
Inclusion Criteria:
- Baseline CT and 5 years follow-up CT including parts of the lumbar spine
Exclusion Criteria:
- CT: No sagittal reformations or axial slices ≤3 mm
- CT: No inclusion of at least T6 to L4
- No BMI data available
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incident vertebral fracture
Time Frame: From enrollment to minimum 5 years follow-up
|
CT based detection of vertebral fractures
|
From enrollment to minimum 5 years follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical fragility fractures
Time Frame: From enrollment to maximum 10 years follow-up (upon availability)
|
Fragility fractures from medical records (retrospective)
|
From enrollment to maximum 10 years follow-up (upon availability)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 25, 2003
Primary Completion (Actual)
October 15, 2021
Study Completion (Actual)
October 15, 2021
Study Registration Dates
First Submitted
March 17, 2026
First Submitted That Met QC Criteria
March 17, 2026
First Posted (Actual)
March 23, 2026
Study Record Updates
Last Update Posted (Actual)
March 31, 2026
Last Update Submitted That Met QC Criteria
March 25, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTFU5YTUM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
National Taiwan University HospitalNational Taiwan UniversityNot yet recruitingOsteoporosis | Postmenopausal Osteoporosis | Postmenopausal Osteopenia | Primary OsteoporosisTaiwan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
AmgenCompletedPostmenopausal Osteoporosis (PMO)Japan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisPakistan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisBelgium, Luxembourg, Austria, Greece, Ireland
-
Hoffmann-La RocheNo longer availablePostmenopausal OsteoporosisTaiwan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisPoland, Slovakia, Hungary, Russian Federation, Latvia, Romania, Slovenia
Clinical Trials on Opportunistic osteoporosis screening
-
Fred Hutchinson Cancer CenterCompleted
-
16 Bit Inc.Sunnybrook Health Sciences Centre; AmgenCompleted
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Catalan Institute of Health; University Rovira i Virgili; Jordi Gol Primary Health...UnknownAtrial Fibrillation
-
Erasmus Medical CenterCompletedHIV/AIDS | Opportunistic Infections, HIV RelatedNetherlands
-
National Taiwan University HospitalNational Health Research Institutes, TaiwanRecruitingFrailty | Sarcopenia | OsteoporosisTaiwan
-
Region StockholmKarolinska InstitutetEnrolling by invitationCardiovascular Diseases | Type 2 DiabetesSweden
-
Umeå UniversityKarolinska Institutet; Uppsala University; Göteborg University; Queen Mary University... and other collaboratorsNot yet recruitingMenopause | Opportunistic SalpingectomySweden
-
Radboud University Medical CenterCatharina Ziekenhuis EindhovenEnrolling by invitationMenopause | Salpingectomy | Tubal LigationNetherlands
-
Radboud University Medical CenterCatharina Ziekenhuis EindhovenActive, not recruitingSTOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands (STOPOVCA)Ovarian Cancer | Risk ReductionNetherlands
-
Agency for Healthcare Research and Quality (AHRQ)CompletedCoronary Artery Disease | Hypertension | Diabetes Mellitus | Osteoporosis | HyperlipidemiaUnited States